Who We Are
Explore the links to the left to learn more about who we are.
Establishing a deeper knowledge of disease states and forging multi-disciplinary collaborations have become essential to finding safe and effective new therapies. KHI is a powerful example of this successful formula.
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research
US Food and Drug Administration